BMRN Historical PE Ratio image   This BMRN PE ratio history page last updated 10/28/2022
BMRN Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
10/26/2022
92.10-0.04-0.16NA
Q2 2022
8/3/2022
88.400.592.3637.5
Q1 2022
4/27/2022
80.310.170.68118.1
Q4 2021
2/23/2022
82.52-0.32-1.28NA
Q3 2021
10/27/2021
71.72-0.20-0.80NA
Q2 2021
7/28/2021
78.730.070.28281.2
Q1 2021
4/29/2021
80.180.090.36222.7
Q4 2020
2/25/2021
81.760.120.48170.3
Q3 2020
11/5/2020
75.054.0116.044.7
Q2 2020
8/4/2020
119.83-0.16-0.64NA
Q1 2020
4/29/2020
94.710.441.7653.8
Q4 2019
2/26/2020
91.220.080.32285.1
Q3 2019
10/23/2019
69.010.301.2057.5
Q2 2019
8/1/2019
81.00-0.29-1.16NA
Q1 2019
4/25/2019
85.31-0.32-1.28NA
Q4 2018
2/21/2019
88.81-0.03-0.12NA
Q3 2018
10/25/2018
96.43-0.07-0.28NA
Q2 2018
8/2/2018
102.05-0.09-0.36NA
Q1 2018
4/25/2018
81.53-0.26-1.04NA
Q4 2017
2/22/2018
84.000.030.12>500
Q3 2017
10/26/2017
82.53-0.07-0.28NA
Q2 2017
8/2/2017
87.64-0.21-0.84NA
Q1 2017
5/4/2017
97.78-0.09-0.36NA
Q4 2016
2/23/2017
89.29-0.53-2.12NA
Q3 2016
10/27/2016
81.02-0.26-1.04NA
Q2 2016
8/4/2016
99.62-2.61-10.44NA
Q1 2016
4/28/2016
85.10-0.17-0.68NA
Q4 2015
2/25/2016
76.410.391.5649.0
Q3 2015
10/29/2015
113.80-0.57-2.28NA
Q2 2015
8/3/2015
147.17-0.51-2.04NA
Q1 2015
4/30/2015
112.05-0.16-0.64NA
Q4 2014
2/25/2015
107.50-0.47-1.88NA
Q3 2014
10/23/2014
75.010.502.0037.5
Q2 2014
7/30/2014
61.09-0.23-0.92NA
Q1 2014
5/1/2014
60.31-0.01-0.04NA
Q4 2013
2/26/2014
82.56-0.44-1.76NA
Q3 2013
10/24/2013
68.96-0.38-1.52NA
Q2 2013
7/25/2013
63.82-0.16-0.64NA
Q1 2013
4/25/2013
62.87-0.31-1.24NA
Q4 2012
2/21/2013
53.27-0.43-1.72NA
Q3 2012
10/25/2012
38.15-0.04-0.16NA
Q2 2012
8/1/2012
38.02-0.27-1.08NA
Q1 2012
3/31/2012
NA-0.21-0.84NA
BMRN PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
10/26/2022
92.10-0.040.40230.2
Q2 2022
8/3/2022
88.400.590.24368.3
Q1 2022
4/27/2022
80.310.17-0.28NA
Q4 2021
2/23/2022
82.52-0.32-0.36NA
Q3 2021
10/27/2021
71.72-0.200.08>500
Q2 2021
7/28/2021
78.730.074.2918.4
Q1 2021
4/29/2021
80.180.094.0619.7
Q4 2020
2/25/2021
81.760.124.4118.5
Q3 2020
11/5/2020
75.054.014.3717.2
Q2 2020
8/4/2020
119.83-0.160.66181.6
Q1 2020
4/29/2020
94.710.440.53178.7
Q4 2019
2/26/2020
91.220.08-0.23NA
Q3 2019
10/23/2019
69.010.30-0.34NA
Q2 2019
8/1/2019
81.00-0.29-0.71NA
Q1 2019
4/25/2019
85.31-0.32-0.51NA
Q4 2018
2/21/2019
88.81-0.03-0.45NA
Q3 2018
10/25/2018
96.43-0.07-0.39NA
Q2 2018
8/2/2018
102.05-0.09-0.39NA
Q1 2018
4/25/2018
81.53-0.26-0.51NA
Q4 2017
2/22/2018
84.000.03-0.34NA
Q3 2017
10/26/2017
82.53-0.07-0.90NA
Q2 2017
8/2/2017
87.64-0.21-1.09NA
Q1 2017
5/4/2017
97.78-0.09-3.49NA
Q4 2016
2/23/2017
89.29-0.53-3.57NA
Q3 2016
10/27/2016
81.02-0.26-2.65NA
Q2 2016
8/4/2016
99.62-2.61-2.96NA
Q1 2016
4/28/2016
85.10-0.17-0.86NA
Q4 2015
2/25/2016
76.410.39-0.85NA
Q3 2015
10/29/2015
113.80-0.57-1.71NA
Q2 2015
8/3/2015
147.17-0.51-0.64NA
Q1 2015
4/30/2015
112.05-0.16-0.36NA
Q4 2014
2/25/2015
107.50-0.47-0.21NA
Q3 2014
10/23/2014
75.010.50-0.18NA
Q2 2014
7/30/2014
61.09-0.23-1.06NA
Q1 2014
5/1/2014
60.31-0.01-0.99NA
Q4 2013
2/26/2014
82.56-0.44-1.29NA
Q3 2013
10/24/2013
68.96-0.38-1.28NA
Q2 2013
7/25/2013
63.82-0.16-0.94NA
Q1 2013
4/25/2013
62.87-0.31-1.05NA
Q4 2012
2/21/2013
53.27-0.43-0.95NA
Q3 2012
10/25/2012
38.15-0.04NANA
Q2 2012
8/1/2012
38.02-0.27NANA
Q1 2012
3/31/2012
NA-0.21NANA
Quotes delayed 20 minutes

Email EnvelopeFree BMRN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biomarin Pharmaceutical (BMRN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BMY PE Ratio History
BNGO PE Ratio History
BOLT PE Ratio History
BPMC PE Ratio History
BPTH PE Ratio History
BRKR PE Ratio History
BRTX PE Ratio History
BSGM PE Ratio History
BSX PE Ratio History
BTAI PE Ratio History
How should the BMRN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Biomarin Pharmaceutical. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BMRN Historical PE Ratio page.

What is the average historical PE for BMRN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BMRN historical PE ratio using the annualized quarterly earnings method works out to 119.8.

What is the average historical PE for BMRN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BMRN historical PE ratio using the TTM earnings method works out to 129.1.

What is the average historical PE for BMRN based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The BMRN historical PE ratio using the annualized median TTM earnings method works out to 0.28.

On this page we presented the BMRN Historical PE Ratio information for Biomarin Pharmaceutical' stock. The average BMRN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 119.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BMRN historical PE based on this TTM earnings result method is 129.1. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BMRN historical PE result, against the recent PE: when this page was posted on 10/27/2022, the most recent closing price for BMRN had been 85.73, and the most recent quarterly earnings result, annualized, was 2.36. Meanwhile, the most recent TTM earnings summed to 0.4. From these numbers, we calculate the recent BMRN PE on 10/27/2022 based on annualized quarterly EPS was 36.3. Based on BMRN's history, that recent PE is low relative to the historical average, with the recent PE 69.7% lower than the historical average PE across our data set for Biomarin Pharmaceutical. Looking at the recent BMRN PE on 10/27/2022 based on TTM EPS, we calculate the ratio at 214.3. Based on BMRN's history, that recent PE is elevated relative to the historical average, with the recent PE 66.0% higher than the historical average PE across our Biomarin Pharmaceutical data set with TTM EPS used in the calculation at each period.

Another interesting BMRN historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for BMRN, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for BMRN, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.32, -0.04, 0.17, and 0.59. We then toss out the highest and lowest result, and then take the average of those two middle numbers — -0.04 and 0.17 — which gives us the median of 0.07. Basically the way to think about this 0.07 number is this: for the trailing four earnings reports, 0.07 marks the "middle ground" number where BMRN has reported a value higher than 0.07 half the time, and has reported a value lower than 0.07 half the time. Annualizing that median value then gets us to 0.28/share, which we use as the denominator in our next PE calculation. With 85.73 as the numerator (as of 10/27/2022), the calculation is then 85.73 / 0.28 = 306.2 as the BMRN PE ratio as of 10/27/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on BMRN or any other given stock, valuation analysis for BMRN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Biomarin Pharmaceutical PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BMRN. Thanks for visiting, and the next time you need to research BMRN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CRCT Average Annual Return, Institutional Holders of AORT, Institutional Holders of MFNC.

 

BMRN Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.